• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

UNO Tsukasa  宇野 司

ORCIDConnect your ORCID iD *help
Researcher Number 30400138
Other IDs
Affiliation (based on the past Project Information) *help 2008 – 2010: University of the Ryukyus, 医学部附属病院, 教授
Review Section/Research Field
Principal Investigator
Medical pharmacy
Keywords
Principal Investigator
オメプラゾール光学異性体 / オメプラゾール / HPLC / AUC / CYP2C19 / 代謝学 / 薬物動態
  • Research Projects

    (1 results)
  • Research Products

    (16 results)
  •  The prediction of Helicobacter Pylori eradication using CYP2C19 activity determined by limited plasma concentration of omeprazole enantiomersPrincipal Investigator

    • Principal Investigator
      UNO Tsukasa
    • Project Period (FY)
      2008 – 2010
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Medical pharmacy
    • Research Institution
      University of the Ryukyus

All 2011 2010 2009 2008

All Journal Article Presentation

  • [Journal Article] Comparison of drug sensitivity and genotypes of clinically isolated strains of levofloxacin-resistant Streptococcus pneumoniae obtained from Okinawa Island, the Japanese main island and Hong Kong.2011

    • Author(s)
      Sunagawa S, Fujita J, Higa F, Tateyama M, Haranaga S, Nakasone I, Yamane N, Uno T.
    • Journal Title

      J Antibiot (Tokyo) in press

    • NAID

      10030639796

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20590150
  • [Journal Article] Effects of the CYP2D6*10 allele on the steady-state plasma concentrations of aripiprazole and its active metabolite, dehydroaripiprazole, in Japanese patients with schizophrenia.2011

    • Author(s)
      Suzuki T, Mihara K, Nakamura A, Nagai G, Kagawa S, Nemoto K, Ohta I, Arakaki H, Uno T, Kondo T.
    • Journal Title

      Ther Drug Monit 33

      Pages: 21-4

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20590150
  • [Journal Article] Standard warfarin dose in a patient with the CYP2C9*3/*3 genotype leads to hematuria.2010

    • Author(s)
      Goto T, Miura M, Murata A, Terata K, Uno T, Yamamoto K, Abe Y.
    • Journal Title

      Clin Chim Acta 6

      Pages: 1375-1377

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20590150
  • [Journal Article] Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers.2010

    • Author(s)
      Akamine Y, Miura M, Sunagawa S, Kagaya H, Yasui-Furukori N, Uno T.
    • Journal Title

      Xenobiotica 40

      Pages: 782-729

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20590150
  • [Journal Article] Clinical pharmacokinetics of fexofenadine enantiomers.2010

    • Author(s)
      Miura M, Uno T.
    • Journal Title

      Expert Opin Drug Metab Toxicol 6

      Pages: 69-74

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20590150
  • [Journal Article] A sensitive column-switching HPLC method for aripiprazole and dehydroaripiprazole and its application to human pharmacokinetic studies.2010

    • Author(s)
      Akamine Y, Yasui-Furukori N, Kojima M, Inoue Y, Uno T.
    • Journal Title

      J Sep Sci 33

      Pages: 3292-3298

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20590150
  • [Journal Article] Effects of the P-glycoprotein Inducer Carbamazepine on Fexofenadine Pharmacokinetics.2009

    • Author(s)
      Yamada S, Yasui-Furukori N, Akamine Y, Kaneko S, Uno T.
    • Journal Title

      Ther Drug Monit 31

      Pages: 764-768

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20590150
  • [Journal Article] Enantioselective disposition of fexofenadine with the P-glycoprotein inhibitor verapamil.2009

    • Author(s)
      Sakugawa T, Miura M, Hokama N, Suzuki T, Tateishi T, Uno T.
    • Journal Title

      Br J Clin Pharmacol 67

      Pages: 535-40

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20590150
  • [Journal Article] Limited frequency of the CYP2C19^*17 allele and its minor role in a Japanese population.2008

    • Author(s)
      Sugimoto K, Uno T, Yamazaki H, Tateishi T
    • Journal Title

      Br J Clin Pharmacol 65

      Pages: 437-439

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20590150
  • [Journal Article] The different effects of itraconazole on the pharmacokinetics of fexofe nadine enantiomers.2008

    • Author(s)
      Tateishi T, Miura M, Suzuki T, Uno T
    • Journal Title

      Br J Clin Pharmacol 65

      Pages: 693-700

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20590150
  • [Journal Article] The role of CYP2C19 in the R-warfarin pharmacokinetics and its inter action by omeprazole.2008

    • Author(s)
      Uno T, Sugimoto T, Sugawara K, Tateishi T
    • Journal Title

      Ther Drug Monit 30

      Pages: 276-281

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20590150
  • [Journal Article] The effect of CYP2C19 genotypes on the pharmacokinetics of warfarin enantiomers.2008

    • Author(s)
      Uno T, Sugimoto T, Sugawara K, Tateishi T
    • Journal Title

      J Clin Pharm Ther 33

      Pages: 67-73

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20590150
  • [Journal Article] The different effects of itraconazole on the pharmacokinetics of fexofenadine enantiomers.2008

    • Author(s)
      Tateishi T, Miura M, Suzuki T, Uno T
    • Journal Title

      Br J Clin Pharmacol 65

      Pages: 693-700

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20590150
  • [Journal Article] Estimation of the area under the concentration-time curve of racemic lansoprazole by using limited plasma concentration of lansoprazole enantiomers.2008

    • Author(s)
      Niioka T, Miura M, Uno I, Yasui-Furukori N, Hayakari M, Tateishi T, Suzuki T
    • Journal Title

      Eur J Clin Pharmacol 64

      Pages: 503-509

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20590150
  • [Journal Article] Effects of the CYP3A5 genotype on omeprazole sulfoxidation in CYP2C19PMS.2008

    • Author(s)
      Sugimoto K, Uno T, Tateishi T
    • Journal Title

      Eur J Clin Pharmacol 64

      Pages: 583-587

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20590150
  • [Presentation] ラベプラソールとその主代謝物の高感度定量によるCYP2C19遺伝子型に関連したCYP3AまたはP-gp阻害剤とのin vivo併用効果2008

    • Author(s)
      外間 惟夫, 清水 美貴子, 立石 智則, 宇野 司
    • Organizer
      日本TDM学会
    • Place of Presentation
      東京都江戸川区
    • Data Source
      KAKENHI-PROJECT-20590150

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi